1. Mengtian Cui, Qingfang Zhao, Jing Wang, Yang Si, Shan Cheng*, Wei Ding*.ATF6-mediated unfolded protein response facilitates AAV2 transduction by releasing the suppression of AAV receptor on ER stress.J Virol.2022.96(3).e0110321.SCI |
2. Huan Niu, Meng Zhao, Jing Huang, Jing Wang, Yang Si, Shan Cheng*, Wei Ding.UHMK1-dependent phosphorylation of Cajal body protein coilin alters 5-FU sensitivity in colon cancer cells.Cell Commun Signal.2022.20(1).18.SCI |
3. Jing Huang, Mu Hu, Huan Niu, Jing Wang, Yang Si, Shan Cheng*, Wei Ding*.Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels.BMC Cancer.2021.21(1).750.SCI |
4. Jing Niu, Rui-Qi Gao, Meng-Tian Cui, Chen-Guang Zhang, Shen-Tao Li, Shan Cheng*, Wei Ding*.Suppression of TCAB1 expression induced cellular senescence by lessening proteasomal degradation of p21 in cancer cells.Cancer Cell Int.2021.21(1).26.SCI |
5. Yang F, Hu M, Chang S, Huang J, Si Y, Wang J, Cheng S*, Jiang WG.Alteration in the sensitivity to crizotinib by Na+/H+ exchanger regulatory factor 1 is dependent to its subcellular localization in ALK-positive lung cancers.BMC Cancer.2020.20(1).202.SCI |
6. 黄晶, 牛欢, 程杉*.真核基因剪接作用的调控机理及其在人类疾病中作用的研究进展.生理科学进展.2019.50(6).451. |
7. Cui M, Lu Y, Tang C, Zhang R, Wang J, Si Y, Cheng S*, Ding W.A Generic Method for Fast and Sensitive Detection of Adeno-Associated Viruses Using Modified AAV Receptor Recombinant Proteins.Molecules.2019.24(21).pii: E3973..SCI |
8. Hao C, Cui Y, Chang S, Huang J, Birkin E, Hu M, Zhi X, Li W, Zhang L, Cheng S*, Jiang WG*.OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase.Sci Rep.2019.9(1).18101.SCI |
9. Huang Jing; Chang Siyuan; Lu Yabin; Wang Jing, Si Yang, Zhang Lijian, Cheng Shan*, Jiang Wenguo.Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells.Cancer Cell Int.2019.9.306.SCI |
10. Hao C, Cui Y, Hu MU, Zhi X, Zhang L, Li W, Wu W, Cheng S*, Jiang WG*.OPN-a Splicing Variant Expression in Non-small Cell Lung Cancer and its Effects on the Bone Metastatic Abilities of Lung Cancer Cells In Vitro.Anticancer Res.2017.37(5).2245-2254.SCI |
11. Yang F, Gu Y, Zhao Z, Huang J, Jiang WG, Cheng S*.NHERF1 Suppresses Lung Cancer Cell Migration by Regulation of Epithelial-Mesenchymal Transition.Anticancer Res.2017.37(8).4405-4414.SCI |
12. Yanan Gu#, Hefen Yu#, Chengcheng Hao, Tracey A Martin, Rachel Hargest, Junqi He, Shan Cheng*, Wen G Jiang*.NHERF1 regulates the progression of colorectal cancer through the interplay with VEGFR2 pathway.Oncotarget.2017.8(5).7753-7765. |
13. Guifang Du, Yanan Gu, Chengcheng Hao, Zhu Yuan, Junqi He, Wen G Jiang, Shan Cheng *. .The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.Oncotarget.2016.7(20).29440-29453. |
14. Guifang Du, Chengcheng Hao, Yanan Gu, Zhiyan Wang, Wen G Jiang, Junqi He*, Shan Cheng*.A mutation of PDZ protein NHERF1 isolated from human Breast cancer crippled inhibition on epidermal growth factor receptor signaling.Anticancer Res.2016.36 (3).1165-1173.SCI |
15. Meng Zhao, Wang Jia, Wen G Jiang, Pilin Wang, Guifang Du, Shan Cheng*, Maomin Song*.ADAM29 expression in human breast cancer and its effects on breast cancer cells in vitro.Anticancer Res.2016.36 (3).1251-1258.SCI |
16. Hao C, Wang Z, Gu Y, Jiang WG, Cheng S*.Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-Analysis.Biomed Res Int.2016.2016.7310694.SCI |
17. Guifang Du#, Xiaomei Yang#, Mu Hu, Chengcheng Hao, Yanan Gu, Xiuyi Zhi, Wen G. Jiang, Junqi He*, Shan Cheng*.Designing a novel high-throughput AlphaLISA assay to quantify plasma NHERF1 as a non-small cell lung cancer biomarker.RSC Adv.2015.5.84164-84171.SCI |
18. Shan Cheng#, Yang Li#, Ying Yang, Duiping Feng, Longyan Yang, Qian Ma, Shuai Zheng , Ran Meng, Shuhui Wang, Songlin Wang, Wen G. Jiang, Junqi He.Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.Febs Lett.2013.587.3289-3295.SCI |
19. Cheng S, Martin TA, Teng X, Jiang WG*..Putative Breast Tumor Suppressor TACC2 Suppresses the Aggressiveness of Breast Cancer Cells through a PLCγ Pathway.Current Signal Transduction Therapy.2011.6.55-64.SCI |